Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.08
-0.10 (-1.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Molecular Partners AG Employees
Molecular Partners AG had 168 employees as of December 31, 2023. The number of employees decreased by 8 or -4.45% compared to the previous year.
Employees
168
Change (1Y)
-8
Growth (1Y)
-4.45%
Revenue / Employee
$42,420
Profits / Employee
-$442,374
Market Cap
175.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Coherus BioSciences | 306 |
Alector | 244 |
Sight Sciences | 214 |
Genfit | 159 |
Nektar Therapeutics | 137 |
BrainsWay | 134 |
MediWound | 100 |
MOLN News
- 4 days ago - Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January - GlobeNewsWire
- 13 days ago - Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024 - GlobeNewsWire
- 6 weeks ago - Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 - GlobeNewsWire
- 7 weeks ago - Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going - GlobeNewsWire
- 2 months ago - Molecular Partners Announces Pricing of $20 Million Underwritten Offering - GlobeNewsWire
- 2 months ago - Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 - GlobeNewsWire
- 2 months ago - Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics - GlobeNewsWire
- 2 months ago - Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting - GlobeNewsWire